000 01405 a2200397 4500
005 20250516080532.0
264 0 _c20120604
008 201206s 0 0 eng d
022 _a1553-7358
024 7 _a10.1371/journal.pcbi.1002347
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aShigemizu, Daichi
245 0 0 _aUsing functional signatures to identify repositioned drugs for breast, myelogenous leukemia and prostate cancer.
_h[electronic resource]
260 _bPLoS computational biology
_cFeb 2012
300 _ae1002347 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, N.I.H., Extramural
650 0 4 _aBreast Neoplasms
_xdrug therapy
650 0 4 _aComputational Biology
_xmethods
650 0 4 _aDatabases, Factual
650 0 4 _aDrug Discovery
650 0 4 _aDrug Repositioning
650 0 4 _aFemale
650 0 4 _aGene Expression Profiling
_xmethods
650 0 4 _aHumans
650 0 4 _aLeukemia, Myeloid
_xdrug therapy
650 0 4 _aMale
650 0 4 _aProstatic Neoplasms
_xdrug therapy
650 0 4 _aSignal Transduction
700 1 _aHu, Zhenjun
700 1 _aHung, Jui-Hung
700 1 _aHuang, Chia-Ling
700 1 _aWang, Yajie
700 1 _aDeLisi, Charles
773 0 _tPLoS computational biology
_gvol. 8
_gno. 2
_gp. e1002347
856 4 0 _uhttps://doi.org/10.1371/journal.pcbi.1002347
_zAvailable from publisher's website
999 _c21556896
_d21556896